Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
FEBS Letters|June 24, 2020
The cytochrome bc1 complex as an antipathogenic targetNicholas Fisher, Brigitte Meunier, Giancarlo A BiaginiPest Management Science|May 25, 2005
Re-examination of inhibitor resistance conferred by Qo-site mutations in cytochrome b using yeast as a model systemNicholas Fisher, Brigitte MeunierPlos One|August 17, 2013
Reconstructing the Qo site of Plasmodium falciparum bc 1 complex in the yeast enzymeCindy Vallières, Nicholas Fisher, Brigitte MeunierTrends in Parasitology|May 15, 2007
The malaria parasite type II NADH:quinone oxidoreductase: an alternative enzyme for an alternative lifestyleNicholas Fisher, Patrick G Bray, Stephen A Ward, et al.Methods in Enzymology|April 8, 2009
Chapter 17 Type II NADH: quinone oxidoreductases of Plasmodium falciparum and Mycobacterium tuberculosis kinetic and high-throughput assaysNicholas Fisher, Ashley J Warman, Stephen A Ward, et al.Antimicrobial Agents and Chemotherapy|May 2, 2012
HDQ, a potent inhibitor of Plasmodium falciparum proliferation, binds to the quinone reduction site of the cytochrome bc1 complexCindy Vallières, Nicholas Fisher, Thomas Antoine, et al.Current Opinion in Chemical Biology|June 24, 2010
Inhibiting Plasmodium cytochrome bc1: a complex issueVictoria Barton, Nicholas Fisher, Giancarlo A Biagini, et al.European Journal of Biochemistry|March 20, 2004
Disruption of the interaction between the Rieske iron-sulfur protein and cytochrome b in the yeast bc1 complex owing to a human disease-associated mutation within cytochrome bNicholas Fisher, Ingrid Bourges, Philip Hill, et al.Molecular Pharmacology|March 6, 2008
Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complexGiancarlo A Biagini, Nicholas Fisher, Neil Berry, et al.FEBS Letters|March 26, 2018
The antimalarial compound ELQ-400 is an unusual inhibitor of the bc1 complex, targeting both Qo and Qi sitesZehua Song, Bogdan I Iorga, Pierre Mounkoro, et al.Pageof 19